In recent years, better mechanical ventilation strategies and guidelines to decrease ventilation-related trauma and facilitate weaning have provided substantial benefits to critically ill patients [1] . Prevention of ventilator-associated pneumonia (VAP) remains a challenge, however. VAP is associated with increased morbidity,
longer duration of mechanical ventilation, longer lengths of intensive care unit (ICU) and hospital stay, higher costs [2, 3] , and, probably, increased mortality [4] . A recent international consensus panel suggested that VAP may be a marker for quality of care and ICU performance [4] .
Early-onset VAP (EOP) should be distinguished from late-onset VAP: the microorganisms involved are different [5] ; immunoparalysis seems to make a smaller contribution to the pathogenesis of EOP, so that immunomodulation is less likely to provide effective prevention [6] ; and the impact on outcomes may be different [7] . EOP deserves special attention because it accounts for approximately one-half of the cases of nosocomial pneumonia [8] and because effective preventive measures, should any exist, may be different from those capable of protecting against late-onset VAP Figure 1 . Frequencies of infection with gram-positive and gram-negative bacteria, according to the day of early-onset ventilator-associated pneumonia (EOP). [5] . In this prospective, multicenter study, we sought to identify risk factors for EOP, particularly factors that could be targeted by preventive measures.
PATIENTS AND METHODS
Data were recorded prospectively during a 3-year period (1 January 1998 through 31 December 2000) in the medical and surgical ICUs of 5 university-affiliated hospitals in France. There were 2 medical ICUs (Louis Mourier-Colombes Hospital and Saint Louis Hospital, both in Paris), 2 medical-surgical ICUs (Saint Joseph Hospital, Paris, and Avicenne Hospital, Bobigny), and 1 surgical ICU (Antoine Béclère Hospital, Clamart). Data were recorded for all patients who were 116 years of age and spent 148 h in the ICU. For the study, we retrospectively selected from this database all patients who received mechanical ventilatory support for у48 h starting no more than 12 h after ICU admission.
Data collection and baseline data. Data on clinical features, laboratory findings, and treatments received from ICU admission to ICU discharge were collected prospectively. Longterm health status and comorbidities were evaluated using the McCabe scale and the APACHE II score, respectively [9, 10] . The extent of organ failure was measured using the Logistic Organ Dysfunction (LOD) score [11] and the Sepsis-related Organ Failure Assessment (SOFA) score [12] . The investigators were closely involved in establishing the database. All codes and definitions were created before the study. For each patient, a report form was completed daily by a senior physician and was then reviewed by another senior physician before data were entered. The admission day was defined as the interval from ICU admission to 8:00 a.m. the next day, and each subsequent day was defined as the 24-h interval from 8:00 a.m. to 8:00 a.m. Transfer from a ward (defined as ICU admission after 124 h on a ward), ICU outcomes, and hospital outcomes were recorded. There were no missing clinical data.
None of the study ICUs used selective digestive tract decontamination or continuous aspiration of subglottic secretions. Patients were placed in the semirecumbent position unless they had undergone abdominal surgery or had shock refractory to vasoactive therapy. Administration of stress ulcer prophylaxis was at the discretion of the attending physician. Enteral feeding was used, and gastric residual volumes were monitored.
The worst Glasgow Coma Scale (GCS) value was recorded daily, both as the actual score determined after treatment for the initial organ failure (with ventilatory support and with or without sedation) and as the estimated score, which was defined as the score the patient would have without endotracheal intubation or sedation. Before the analyses, because intermediate scores may lack reproducibility, we defined 3 GCS categories: !6, 6-13, and 113. Unplanned extubation was defined as reported elsewhere (i.e., self-extubation plus reintubation after weaning) [13] and was recorded prospectively.
Definition of EOP. EOP was defined as VAP diagnosed from day 3 to day 7 of mechanical ventilation [8, 14, 15] . Suspected EOP was defined as the development of persistent pulmonary infiltrates noted on chest radiographs in combination with purulent tracheal secretions and/or body temperature of у38.5 ЊC or р36.5 ЊC, and/or peripheral blood leukocyte count of у or р leukocytes/L [16] . All 9 9 10 ϫ 10 4 ϫ 10 patients with suspected EOP underwent fiberoptic bronchoscopy with protected specimen brush and/or bronchoalveolar lavage (BAL) or single-sheathed blind plugged telescopic catheter specimen collection before receiving antimicrobial therapy [2, 4, 16] . Confirmed EOP was defined as a positive culture result for a protected specimen brush (у10 3 cfu/mL), plugged telescopic catheter specimen (у10 3 cfu/mL), or a BAL fluid specimen (у10 4 cfu/mL). Multidrug-resistant strains were defined as Pseudomonas aeruginosa resistant to ticarcillin, imipenem, and/or ceftazidime; Staphylococcus aureus resistant to methicillin; and Acinetobacter baumannii or Enterobacteriaceae resistant to ceftazidime.
Statistical analysis. Data are presented as medians and interquartile ranges (IQRs). Risk factors for EOP were selected by univariate analysis using Fisher's exact test for qualitative variables and the Mann-Whitney U test for quantitative variables. For the multivariate analysis, all variables associated with the occurrence of EOP at the .1 level of risk were introduced in a forward stepwise logistic regression model. ORs were calculated with their 95% CIs. Antibiotic therapy used during the first 48 h of ICU stay was introduced either as a nominal variable (0, 1, or у1 antibiotic) or as therapeutic classes (aminoglycosides, cephalosporins, penicillin plus a b-lactamase inhibitor, or fluoroquinolones). Statistical analysis was performed using SAS software, version 8.0 (SAS Institute).
RESULTS
Among the 1602 patients admitted during the study period to the 5 participating ICUs, 747 needed mechanical ventilatory support. Of these patients, 158 (21.2%) experienced a first episode of VAP, with a median time from ICU admission to onset of 7 days (IQR, 4-12 days). Of these 158 episodes, 80 met our definition of EOP. Median time from ICU admission to EOP diagnosis was 4 days (IQR, 2-5 days). For these 80 cases of EOP, 110 microorganisms were recovered (figure 1), the most common being P. aeruginosa ( ) , S. aureus n p 23 ( ), Enterobacteriaceae ( ), and Haemophilus spen p 17 n p 23 cies (
). In 17 episodes, there was у1 multidrug-resistant n p 12 strain (7 strains of P. aeruginosa resistant to ticarcillin, ceftazidime, or imipenem; 6 strains of S. aureus resistant to methicillin; 3 strains of Enterobacteriaceae resistant to ceftazidime; and 1 strain of A. baumannii resistant to ceftazidime). Tables 1 and 2 report patient characteristics at admission and during the ICU stay, as well as the univariate comparison between patients with and patients without EOP. No differences were found with regard to age, comorbidities, or location before ICU admission, although patients with EOP were more likely to be male and to have had cardiac arrest. Patient case-mix, case severity at ICU admission, and number of organ failures at ICU admission, as measured by the LOD score or the SOFA score, were not significantly associated with EOP. Organ failures (as measured by the LOD) on day 1 were more numerous in the patients who subsequently had EOP than in those who did not. Patients with a GCS value of 6-13 were at increased risk nificant increase in the rate of multidrug-resistant strains (EOP due to susceptible and multidrug-resistant bacteria: 23 of the 63 patients receiving these antibiotics and 8 of 17 patients who were not receiving these antibiotics; ), even after ex-P p .43 clusion of EOP due to methicillin-resistant S. aureus or A. baumannii (for which cross-contamination is far more important than antibiotic selection pressure). These antibiotics also did not increase the rate of late-onset pneumonia due to multidrug-resistant strains (78 episodes of late-onset pneumonia; 33 patients with resistant bacteria of the 53 patients receiving these antibiotics vs. 17 patients with resistant bacteria of the 25 patients who were not receiving these antibiotics;
). P p .62 Table 3 reports the results of the multivariable logistic regression. Of the variables available at ICU admission, male sex and an actual GCS value of 6-13 predicted EOP. Four variables were independently associated with EOP: LOD score change on day 1; use of sucralfate; absence of use of aminoglycosides, b-lactams/b-lactamase inhibitors, and third-generation cephalosporins within 48 h after ICU admission; and unplanned extubation within 48 h after ICU admission. EOP was associated with longer durations of ICU and hospital stay but modified neither ICU mortality nor hospital mortality.
DISCUSSION
This prospective multicenter study involving a selected population of patients treated with invasive mechanical ventilation for у48 h starting at ICU admission identified 6 predictors of EOP. Two were patient related-namely, male sex and absence of LOD score improvement on day 1. An intermediate value (6) (7) (8) (9) (10) (11) (12) (13) of the actual GCS on day 1, reflecting either preexisting disease or the effects of therapy, also predicted EOP. The 3 remaining predictors were environmental factors that occurred during the first 48 h of mechanical ventilation-namely, use of sucralfate, occurrence of unplanned extubation, and absence of antimicrobial therapy. More specifically, a marked protective effect was found for use of aminoglycosides, third-generation cephalosporins, and b-lactams/b-lactamase inhibitors within the first 48 h, whereas use of fluoroquinolones, macrolides, and other antibiotics was not protective. The protective effect of antibiotic therapy was greatest when 11 antimicrobial was used.
Although current guidelines suggest that EOP is the type of pneumonia that appears during the first 5 days after intubation [8] , the cutoff of 7 days has also been used by other authors on the basis that it corresponded to the median time of occurrence of pneumonia, and because mechanical ventilation lasting у7 days is associated with increased likelihood of infection with high-risk organisms [14, 15] . Also, the present study, which includes some patients previously treated with antibiotics, is an interpretation of an observational study of daily clinical practice and is not designed specifically to evaluate the effect of antibiotic therapy on EOP. Another point is that none of the participating ICUs used subglottic aspiration, a simple method that decreases or delays the chronic microaspirations through the cuff of endotracheal tubes [17, 18] .
Neurological impairment, as measured by the GCS, may indicate both coma related to a neurological condition (e.g., encephalitis, meningitis, drug overuse, and suicide attempt) or altered consciousness associated with sepsis or critical conditions mimicking sepsis (e.g., pancreatitis, severe burns, and trauma without neurological impairment) [19] [20] [21] . Posttraumatic coma is associated with early VAP [22] but was too rare in our population to explain the association between coma and EOP. We used the actual GCS, which can be measured daily, even in sedated patients. This score reflected both the neurological status and the intensity of sedation used on the first day of the ICU stay. Many studies have found an association between coma as the reason for ICU admission and EOP [23] [24] [25] . This association may be related to the specific immunosuppression associated with coma or sedative therapy [26, 27] . Conceivably, even if some patients with aspiration pneumonia receive antibiotics within the first few days after ICU admission, previous bronchial and alveolar damage may result in vulnerability to infection [28] . Furthermore, continuous intravenous sedation is associated with a longer duration of mechanical ventilation and with a greater risk of repeated intubation [29] , which may increase the risk of VAP. Interruption of the sedative infusion once per day [30] or use of protocol-directed sedation [31] may decrease the duration of mechanical ventilation or of ICU stay. However, unplanned extubation is associated with a 5-fold increase in the risk of VAP [13] and is probably more common among patients receiving light sedation than among those receiving heavy sedation. This should be taken into account when protocol-directed sedation programs are being designed.
The protective effect of antibiotic therapy (cephalosporins and aminoglycosides) in our study is congruent with previous evidence that initial antibiotic therapy reduces the risk of VAP. Cook et al. [25] found a protective effect of initial antibiotic therapy until the tenth day in the ICU. In their study, the median duration of antibiotic therapy for the population of subjects without VAP was 5 days. This protective effect of antibiotics may be related to decreased oropharyngeal colonization [32] . Although we did not observe an increase in the rate of pneumonia due to multidrug-resistant bacteria, antibiotic therapy to prevent EOP cannot be recommended, because it may be associated with an increased incidence of late-onset VAP as a result of changes in the oropharyngeal flora (which determines the microbiological profile of late-onset VAP) [8, 33] . Indiscriminate use of antimicrobial agents in ICU patients may have not only immediate adverse effects (selective pressure over microorganisms, selection of multidrug-resistant mutants, and changes in the etiology and outcome of late-onset pneumonia) but also long-term adverse effects, including the emergence of multidrug-resistant pathogens in the ICU or elsewhere in the hospital, with a heightened risk of severe nosocomial infection. Selective digestive tract decontamination to decrease the risk of colonization or infection with multidrug-resistant strains in patients given parenteral cephalosporins for 4 days [34] [35] [36] decreased the risk of VAP, but this was often associated with adverse effects of antibiotic selection pressure [37] .
It is generally accepted-although not completely demonstrated-that a 24-h course of prophylactic antibiotic therapy is not associated with a sustained risk of emergence of drugresistant colonizing pathogens. A protective effect of a 1-day course of cefuroxime (given immediately after intubation) against EOP was demonstrated in a randomized study that involved patients with coma due to head injury or stroke [38] and was not associated with the emergence of drug-resistant bacteria. Our study suggests that 1 day of prophylactic intravenous antimicrobial therapy may reduce the risk of EOP. This possibility has to be tested in an unselected population of patients receiving mechanical ventilatory support who are subject to close monitoring of potential effects on the oropharyngeal, tracheal, and intestinal flora.
The lower incidence of EOP in patients given aminoglycosides in our study may be ascribable primarily to the widespread use of potentially synergistic antibiotics for empirical therapy in France. Thus, aminoglycosides were never used as the only antibiotic for patients with suspected organ infection. Of interest, in our study, the use of fluoroquinolones was not associated with a decreased risk of EOP. The limited impact of fluoroquinolones on oropharyngeal streptococci and anaerobes probably explains this result. The impact of enteral nutrition, which has been studied previously [39, 40] , was not significant in our multivariable analysis, probably because standard practice in the study ICUs involved avoiding early enteral feeding in critically ill patients.
We found an increased risk of EOP in patients given sucralfate during the first 2 days of mechanical ventilation. Four of 7 meta-analyses addressing this point found a significantly decreased incidence of VAP associated with sucralfate therapy, compared with H 2 -antagonists, with the difference being greatest for EOP [41] . However, few placebo-controlled studies of sucralfate have been reported. One randomized study [42] found a trend toward an increased risk of VAP in the sucralfate group (relative risk, 2.0; 95% CI, 0.79-5.01). Sucralfate use may contribute to the development of pharmacobezoars [43] and esophageal and intestinal obstruction and may promote bacterial growth [44] . Finally, an association between sucralfate use and increased vulnerability to VAP has also been suggested by an epidemiological study involving patients with acute respiratory distress syndrome [44] . The 1.8-fold increase in the risk of EOP in our patients given sucralfate is consistent with this earlier study, suggesting a need for further evaluation of the impact of sucralfate use in ICU patients.
In summary, among patients who received mechanical ventilatory support for 12 days, one-fifth experienced an episode of VAP, which occurred within the first week of ICU stay for one-half of the cases. These cases of EOP are associated with patient-related factors and with sucralfate use and unplanned extubation. Antibiotic use within the first 48 h (b-lactams/blactamase inhibitors, third-generation cephalosporins, and aminoglycosides) confers protection. Whether 1 day of preemptive intravenous antibiotic therapy in patients receiving invasive mechanical ventilatory support reduces the occurrence of early VAP without inducing adverse effects may deserve to be investigated. 
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